2004
DOI: 10.1021/ac0352171
|View full text |Cite
|
Sign up to set email alerts
|

Serum Peptide Profiling by Magnetic Particle-Assisted, Automated Sample Processing and MALDI-TOF Mass Spectrometry

Abstract: Human serum contains a complex array of proteolytically derived peptides (serum peptidome) that may provide a correlate of biological events occurring in the entire organism; for instance, as a diagnostic for solid tumors (Petricoin, E. F.; Ardekani, A. M.; Hitt, B. A.; Levine, P. J.; Fusaro, V. A.; Steinberg, S. M.; Mills, G. B.; Simone, C.; Fishman, D. A.; Kohn, E. C.; Liotta, L. Lancet 2002, 359, 572-577). Here, we describe a novel, automated technology platform for the simultaneous measurement of serum pep… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
363
1
3

Year Published

2005
2005
2016
2016

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 438 publications
(374 citation statements)
references
References 25 publications
6
363
1
3
Order By: Relevance
“…Various types of beads have been used, which include reverse-phase chromatographic beads [17,18] and immobilized metal ion beads [19 -21]. To speed up the collection of analyteadsorbed beads from sample solution, magnetic particles, which can be simply collected using a magnet, were developed [22][23][24]. After collection, the microbeads were washed and placed on sample target, followed by analyzing with MALDI MS.…”
mentioning
confidence: 99%
“…Various types of beads have been used, which include reverse-phase chromatographic beads [17,18] and immobilized metal ion beads [19 -21]. To speed up the collection of analyteadsorbed beads from sample solution, magnetic particles, which can be simply collected using a magnet, were developed [22][23][24]. After collection, the microbeads were washed and placed on sample target, followed by analyzing with MALDI MS.…”
mentioning
confidence: 99%
“…Novel technology was described by Villanueva et al. (2004) where MALD‐TOF MS was used to simultaneously analyze serum proteins; 1691 peptide masses were identified over the whole dataset. Refinement using a Wilcoxon–Mann U ‐test enabled 274 peptide masses to be identified, differentiating GBM patients and controls, correctly classifying 96.4% of predicted samples as cancerous or not.…”
Section: Mass Spectrometrymentioning
confidence: 99%
“…14 The preparative and analytic processes can be sped up considerably with automation. 29,33 What can we exactly obtain with this method? A spectrum profile that shows hundreds of bars.…”
Section: The Proteome Of the Human Serum And Its Examinationmentioning
confidence: 99%